世界のカルバペネム産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Carbapenem Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(QYR20FB06212)・商品コード:QYR20FB06212
・発行会社(調査会社):QYResearch
・発行日:2019年11月
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥686,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,029,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,372,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界のカルバペネム市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。カルバペネムの種類別には、メロペネム、ドリペネム、イミペネム、パニペネム、その他に、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・カルバペネムの種類別市場規模:メロペネム、ドリペネム、イミペネム、パニペネム、その他
・カルバペネムの用途別市場規模:病院、診療所、その他
・カルバペネムの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Pfizer、Savior Lifetec、Sun Pharmaceutical Industries、Kopran、HISUN Pharmaceutical、Haibin Pharmaceutical、United Lab
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

In 2018, the global Carbapenem market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Carbapenem.
This study researches the market size of Carbapenem, presents the global Carbapenem sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Carbapenem in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Carbapenem for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
HISUN Pharmaceutical
Haibin Pharmaceutical
United Lab

Market Segment by Product Type
Meropenem
Doripenem
Imipenem
Panipenem
Others

Market Segment by Application
Hosptials
Clinics
Others

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Carbapenem status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Carbapenem manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Carbapenem are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Carbapenem Market Size Growth Rate by Type
1.3.2 Meropenem
1.3.3 Doripenem
1.3.4 Imipenem
1.3.5 Panipenem
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Carbapenem Market Share by Application (2019-2025)
1.4.2 Hosptials
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Carbapenem Market Size
2.1.1 Global Carbapenem Revenue 2014-2025
2.1.2 Global Carbapenem Sales 2014-2025
2.2 Carbapenem Growth Rate by Regions
2.2.1 Global Carbapenem Sales by Regions 2014-2019
2.2.2 Global Carbapenem Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Carbapenem Sales by Manufacturers
3.1.1 Carbapenem Sales by Manufacturers 2014-2019
3.1.2 Carbapenem Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Carbapenem Revenue by Manufacturers (2014-2019)
3.2.2 Carbapenem Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Carbapenem Market Concentration Ratio (CR5 and HHI)
3.3 Carbapenem Price by Manufacturers
3.4 Key Manufacturers Carbapenem Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Carbapenem Market
3.6 Key Manufacturers Carbapenem Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Meropenem Sales and Revenue (2014-2019)
4.1.2 Doripenem Sales and Revenue (2014-2019)
4.1.3 Imipenem Sales and Revenue (2014-2019)
4.1.4 Panipenem Sales and Revenue (2014-2019)
4.1.5 Others Sales and Revenue (2014-2019)
4.2 Global Carbapenem Sales Market Share by Type
4.3 Global Carbapenem Revenue Market Share by Type
4.4 Carbapenem Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Carbapenem Sales by Application

6 North America
6.1 North America Carbapenem Breakdown Data by Company
6.2 North America Carbapenem Breakdown Data by Type
6.3 North America Carbapenem Breakdown Data by Application
6.4 North America Carbapenem Breakdown Data by Countries
6.4.1 North America Carbapenem Sales by Countries
6.4.2 North America Carbapenem Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Carbapenem Breakdown Data by Company
7.2 Europe Carbapenem Breakdown Data by Type
7.3 Europe Carbapenem Breakdown Data by Application
7.4 Europe Carbapenem Breakdown Data by Countries
7.4.1 Europe Carbapenem Sales by Countries
7.4.2 Europe Carbapenem Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Carbapenem Breakdown Data by Company
8.2 Asia Pacific Carbapenem Breakdown Data by Type
8.3 Asia Pacific Carbapenem Breakdown Data by Application
8.4 Asia Pacific Carbapenem Breakdown Data by Regions
8.4.1 Asia Pacific Carbapenem Sales by Countries
8.4.2 Asia Pacific Carbapenem Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Carbapenem Breakdown Data by Company
9.2 Central & South America Carbapenem Breakdown Data by Type
9.3 Central & South America Carbapenem Breakdown Data by Application
9.4 Central & South America Carbapenem Breakdown Data by Countries
9.4.1 Central & South America Carbapenem Sales by Countries
9.4.2 Central & South America Carbapenem Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Carbapenem Breakdown Data by Type
10.2 Middle East and Africa Carbapenem Breakdown Data by Application
10.3 Middle East and Africa Carbapenem Breakdown Data by Countries
10.3.1 Middle East and Africa Carbapenem Sales by Countries
10.3.2 Middle East and Africa Carbapenem Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Carbapenem
11.1.4 Carbapenem Product Introduction
11.1.5 Pfizer Recent Development
11.2 Savior Lifetec
11.2.1 Savior Lifetec Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Carbapenem
11.2.4 Carbapenem Product Introduction
11.2.5 Savior Lifetec Recent Development
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Carbapenem
11.3.4 Carbapenem Product Introduction
11.3.5 Sun Pharmaceutical Industries Recent Development
11.4 Kopran
11.4.1 Kopran Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Carbapenem
11.4.4 Carbapenem Product Introduction
11.4.5 Kopran Recent Development
11.5 HISUN Pharmaceutical
11.5.1 HISUN Pharmaceutical Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Carbapenem
11.5.4 Carbapenem Product Introduction
11.5.5 HISUN Pharmaceutical Recent Development
11.6 Haibin Pharmaceutical
11.6.1 Haibin Pharmaceutical Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Carbapenem
11.6.4 Carbapenem Product Introduction
11.6.5 Haibin Pharmaceutical Recent Development
11.7 United Lab
11.7.1 United Lab Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Carbapenem
11.7.4 Carbapenem Product Introduction
11.7.5 United Lab Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Carbapenem Sales Channels
12.2.2 Carbapenem Distributors
12.3 Carbapenem Customers

13 Market Forecast
13.1 Global Carbapenem Sales and Revenue Forecast 2019-2025
13.2 Global Carbapenem Sales Forecast by Type
13.3 Global Carbapenem Sales Forecast by Application
13.4 Carbapenem Forecast by Regions
13.4.1 Global Carbapenem Sales Forecast by Regions 2019-2025
13.4.2 Global Carbapenem Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Carbapenem Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Carbapenem Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Carbapenem Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Carbapenem Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Carbapenem Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer



【掲載企業】

Pfizer、Savior Lifetec、Sun Pharmaceutical Industries、Kopran、HISUN Pharmaceutical、Haibin Pharmaceutical、United Lab

★調査レポート[世界のカルバペネム産業:成長傾向・競合分析2019-2025] (コード:QYR20FB06212)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のカルバペネム産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆